Queer Nilayam will be organizing a free health camp for the LGBTQIA+ community in Hyderabad on March 11. Unsplash
MedBound Blog

Hyderabad: Queer Nilayam to Organise Free Health Camp for the LGBTQIA+ Community on March 11

Queer Nilayam is an NGO for the LGBTQIA+ community in Hyderabad. It was established to provide support for the community.

Author : Dr. Amey Patil

The LGBTQIA+ community has always been a marginalized group of people in India. However, they have their requirements that require special attention. Their health needs, in particular, remain unaddressed as their community is considered taboo.

However, QUEER NILAYAM is here to change that. Queer Nilayam is an NGO for the LGBTQIA+ community in Hyderabad. It was established to provide support for the community. Queer Nilayam will be organizing a free health camp for the LGBTQIA+ community in Hyderabad on March 11.

The camp will be organized in the Phoenix Arena, Hitech City, Hyderabad from 10 AM to 4 PM. A panel discussion will take place from 2:30 PM to 3:30 PM by doctors from various hospitals.

The camp will be organized in the Phoenix Arena, Hitech City, Hyderabad from 10 AM to 4 PM. A panel discussion will take place from 2:30 PM to 3:30 PM by doctors from various hospitals.

The camp will provide services like general medicine, group therapy, diabetes, eye testing, blood donations, dental checkup, and many more services for the LGBTQIA+ community.

The camp will provide services like general medicine, group therapy, diabetes, eye testing, blood donations, dental checkup, and many more services for the LGBTQIA+ community.

The camp will have renowned community and medical partners like Maxvision hospitals, YRGCARE, Moberra Foundation, Solidarity Foundation, Mitr Clinic, and many more.

(Input from various media sources)

Stay Sharp After Menopause: How Aerobic Exercise Can Improve Key Thinking Skills

Adhering to Common Lupus Treatment Lowers Risk of Heart Issues

Psilocybin Prevents Chemotherapy-Related Nerve Injury and Associated Symptoms in Preclinical Models

Toward a More Precise Approach to Treating Schizophrenia

Duchenne Muscular Dystrophy Patients Are Focus of GLP-1 Therapy for Obesity Study